Clinical Trial 37392

share

Berlin, NJ 08009


Study Summary:

A Randomized, Open-label, Parallel, Phase 2a Study to Determine the Tolerability, Pharmacokinetics, and Efficacy of APD371 in Subjects with Crohn’s disease experiencing Abdominal Pain


Qualified Participants Must:

• Have had Crohn's disease for at least 3 months
• Have chronic moderate to severe abdominal pain


Qualified Participants May Receive:

Transportation options and compensation up to $850 for time and travel may be available.


Research Site Profile

View Clinic Profile


Study is Available At:

Hassman Research Institute
175 Cross Keys RD.
Berlin, NJ 08009
View Clinic Location

 


If you or someone you care for is interested in participating in this clinical trial and lives within 100 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.